Posted by IsoM on April 16, 2002, at 1:09:12
In reply to Re: Selegiline MAOI patch rejected by FDA, posted by AnnieDonia on April 15, 2002, at 23:03:30
Annie, the way pharmaceutical companies are set up & operate is the same with just about everything else in this corrupt world - the bottom line is 'will the profit be large enough'?
The fact the Selegiline patch works very well for some isn't reason enough for them. I guess they figure there's not a big enough profit margin in it to proceed. One thing that's hopeful is it may be picked up by another company instead.
Another post mentioned a drug study being done on a substance P antagonist labelled MK-869. Merck jumped on it & got to stage III (I think) testing before they realised that people were responding just as well to the placebo & dropped it. They didn't take other factors into consideration &, in my opinion, stopped it prematurely. Some other companies such as Pfizer & Eli Lilly have taken it up instead & are working further with it.
Maybe the same will happen with the Selegiline patch. There's bound to be a few researchers involved who'll note that it did work wonderfully with some & spread the idea or cross over to the competition & they'll decide they don't have a big new winner & will go at it. I really wouldn't be surprised to see it come up with another company. The competition to come up with new or improved ADs is intense & very political too.
poster:IsoM
thread:100963
URL: http://www.dr-bob.org/babble/20020408/msgs/103202.html